Attached files

file filename
EX-10.7 - LOAN AND SECURITY AGREEMENT - MELINTA THERAPEUTICS, INC. /NEW/d226593dex107.htm
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - MELINTA THERAPEUTICS, INC. /NEW/d226593dex11.htm
EX-4.1 - SPECIMEN COMMON STOCK CERTIFICATE OF CEMPRA, INC. - MELINTA THERAPEUTICS, INC. /NEW/d226593dex41.htm
EX-10.8 - SECURED PROMISSORY NOTE - MELINTA THERAPEUTICS, INC. /NEW/d226593dex108.htm
EX-4.6 - GLOBAL AMENDMENT - MELINTA THERAPEUTICS, INC. /NEW/d226593dex46.htm
EX-4.5 - WARRANT AGREEMENT - MELINTA THERAPEUTICS, INC. /NEW/d226593dex45.htm
EX-5.1 - OPINION OF WYRICK ROBBINS YATES & PONTON LLP - MELINTA THERAPEUTICS, INC. /NEW/d226593dex51.htm
S-1/A - CEMPRA HOLDINGS, LLC - AMENDMENT NO. 2 TO FORM S-1 - MELINTA THERAPEUTICS, INC. /NEW/d226593ds1a.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1/A of Cempra Holdings, LLC of our report dated April 29, 2011, except for Note 11, as to which date is October 12, 2011 relating to the financial statements, which appears in such Registration Statement. We also consent to the references to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

Raleigh, North Carolina

December 22, 2011